Shares in Belgian drugmaker Galapagos surged nearly 16 percent on Friday after the company said it had seen positive results from several safety and efficacy trials of its rheumatoid arthritis drug filgotinib.
from Reuters: Health https://ift.tt/2YwbSNG
via
IFTTT
0 comments: